Are the C-reactive protein values and erythrocyte sedimentation rate equivalent when estimating the 28-joint disease activity score in rheumatoid arthritis?

Clinical and Experimental Rheumatology

Volumn 26, Issue 5, 2008, Pages 769-775

  Castrejón, Isabel ^a   Ortiz, Ana M ^a   García Vicuña, Rosario ^a   Lopez Bote, Juan P ^a   Humbría, Alicia ^a   Carmona, Loreto ^b   Gonzalez Alvaro, Isidoro ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b UNIDAD DE INVESTIGACIÓN   (Spain)

Author keywords

C reactive protein; Erythrocyte sedimentation rate; Outcome measures; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN;

ACCURACY; ADULT; AGED; ARTICLE; CALCULATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RATING SCALE; REFERENCE VALUE; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

EID: 57249115820     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. PINCUS T, CALLAHAN LF, SALE WG, BROOKS AL, PAYNE LE, VAUGHN WK: Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984; 27: 864-72,
2. DOAN QV, CHIOU CF, DUBOIS RW: Review of eight pharmacoeconomic studies of the value of biologic DMARDs (adalimumab, etanercept, and infliximab) in the management of rheumatoid arthritis. J Manag Care Pharm 2006; 12: 555-69.
3. VAN DER HEIJDE DM, VAN'T HOF MA, VAN RIEL PL et al.: Judging disease activity in clinical practice in rheumatoid arthritis: First step in the development of a disease activity score. Ann Rheum Dis 1990; 49: 916-20.
4. GRIGOR C, CAPELL H, STIRLING A, MCMAHON AD, LOCK P, VALLANCE R et al.: Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): A single-blind randomised controlled trial. Lancet 2004; 364: 263-9.
5. PREVOO ML, VAN'T HOF MA, KUPER HH, VAN LEEUWEN MA, VAN DE PUTTE LB, VAN RIEL PL: Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
6. FRANSEN J, VAN RIEL PL: DAS remission cut points. Clin Exp Rheumatol 2006; 24: S29-32.
7. GABAY C, KUSHNER I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-54,
8. DEODHAR SD: C-Teactive protein: the best laboratory indicator available for monitoring disease activity. Cleve Clin J Med 1989; 56: 126-30.
9. THOMPSON D, MILFORD-WARD A, WHICHER JT: The value of acute phase protein measurements in clinical practice. Ann Clin Biochem 1992; 29: 123-31.
10. INOUE E, YAMANAKA H, HARA M, TOMATSU T, KAMATANI N: Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values. Ann Rheum Dis 2007; 66: 407-9.
11. MATSUI T, KUGAY, KANEKO A et al.: Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Ann Rheum Dis 2007; 66: 1221-6.
12. VAN GESTEL AM, HAAGSMA CJ, VAN RIEL PL: Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998; 41: 1845-50.
13. WALSH L, DAVIES P, McCONKEY B: Relationship between erythrocyte sedimentation rate and serum C-reactive protein in rheumatoid arthritis. Ann Rheum Dis 1979; 38: 362-3.
14. WARD MM: Relative sensitivity to change of the erythrocyte sedimentation rate and serum C-reactive protein concentration in rheumatoid arthritis. J Rheumatol 2004; 31: 884-95.
15. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
16. KRITCHEVSKY SB, CESARI M, PAHOR M: Inflammatory markers and cardiovascular health in older adults. Cardiovasc Res 2005; 66: 265-75.
17. KHERA A, McGUIRE DK, MURPHY SA et al.: Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 2005; 46: 464-9.